APA (7th ed.) Citation

T, T., J, L., FL, C., A, M., D, Z., I, G., . . . TJ, M. (2026). ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma. Neuro-oncology, 28(7), 1753. https://doi.org/10.1093/neuonc/noag053

Chicago Style (17th ed.) Citation

T, Tzaridis, et al. "ONC206 Demonstrates Potent Antitumorigenic Activity and Is a Potential Novel Therapeutic Strategy for High-risk Medulloblastoma." Neuro-oncology 28, no. 7 (2026): 1753. https://doi.org/10.1093/neuonc/noag053.

MLA (9th ed.) Citation

T, Tzaridis, et al. "ONC206 Demonstrates Potent Antitumorigenic Activity and Is a Potential Novel Therapeutic Strategy for High-risk Medulloblastoma." Neuro-oncology, vol. 28, no. 7, 2026, p. 1753, https://doi.org/10.1093/neuonc/noag053.